WHO warns of superbug spread in Europe
The risk of Klebsiella pneumoniae, which is resistant to carbapenems and other antibiotics, spreading in Europe is high.
The risk of Klebsiella pneumoniae, which is resistant to carbapenems and other antibiotics, spreading in Europe is high. This was reported by TASS in the World Health Organization (WHO).
“The risk of further proliferation is real. The increase in the number of cases is consistent with the spread of resistant strains in health facilities, and the European Centre for Disease Prevention and Control (ECDC) assesses the likelihood of their further spread in EU countries and the European Economic Area as high, especially for strains carrying genetic markers of increased virulence.
In addition, the WHO said that the greatest risk of spreading the bacterium is associated with hospitals and other medical facilities. Among farm animals in EU countries, resistant strains are rarely detected.
RBC sent a request to the WHO.
Klebsiella pneumoniae is a conditionally pathogenic gram-negative capsule bacterium of the family Enterobacteriaceae. It often enters the normal microflora of the intestines, skin and mucous membranes of a person without causing symptoms in healthy people, but with weakened immunity or in medical institutions can cause severe infections.
Earlier, on November 18, Politico, citing the European Center for Disease Prevention and Control (ECDC), reported that from 2019 to 2025, the incidence of bloodstream infections caused by the most antibiotic-resistant bacterium Klebsiella pneumoniae increased by 72%.
At the same time, mortality from bacteria-related infections reaches 40-70%. Some strains have recently acquired resistance to almost all antibiotics, including new ones.
Doctor and scientific journalist Alexei Vodovozov told RBC that Klebsiella pneumoniae is also found in Russian hospitals. According to monitoring data for 2025, it accounted for about 30% of bacterial isolates in hospital-acquired infections. At the same time, according to the expert, the danger is not the bacterium itself, but its individual strains that are resistant to antibiotics.
As noted by the physician, candidate of medical sciences and senior lecturer of the Department of Pharmacology of the Institute of Pharmacy and Medical Chemistry of RNIMU named after N. I. Pirogov Andrey Kondrakhin, due to the resistance of bacteria, it is difficult to choose an effective treatment. In some cases, doctors use combinations of antibiotics of different groups, but such therapy creates a significant burden on the body. The spread of resistant strains is especially dangerous for patients and medical personnel in hospitals.



